Search results for "Glycerides"

showing 10 items of 343 documents

Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the F…

2005

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a nuclear transcription factor regulating multiple genes involved in lipid metabolism. It was shown that a common leucine to valine (L162V) substitution at the PPARalpha gene (PPARA) is functional and affects transactivation activity of PPARalpha ligands, such as PUFA, on a concentration-dependent basis. The current study examined this gene-nutrient interaction in relation to plasma lipid variables in a population-based study consisting of 1003 men and 1103 women participating in the Framingham cohort and consuming their habitual diets. We found significant gene-nutrient interactions between the L162V polymorphism and total PUF…

Malemedicine.medical_specialtyApolipoprotein BAlcohol DrinkingPopulationMedicine (miscellaneous)Peroxisome proliferator-activated receptorPolymorphism Single Nucleotidechemistry.chemical_compoundFramingham Heart StudyInternal medicinemedicineDiabetes MellitusHumansPPAR alphaeducationApolipoproteins CTriglycerideschemistry.chemical_classificationeducation.field_of_studyApolipoprotein C-IIISex CharacteristicsNutrition and DieteticsbiologyTriglycerideSmokingApolipoprotein C-IIILipid metabolismMiddle AgedDietary FatsEndocrinologychemistryAmino Acid SubstitutionCase-Control Studiesbiology.proteinFatty Acids Unsaturatedlipids (amino acids peptides and proteins)FemaleEnergy IntakePolyunsaturated fatty acidThe Journal of nutrition
researchProduct

Lp(a) levels in patients undergoing aorto-coronary bypass surgery.

1992

The aims of this study were to evaluate plasma lipid, apoprotein and Lp(a) levels in patients with severe coronary atherosclerosis undergoing aorto-coronary bypass surgery (BP) and to relate these parameters to the involvement of one or more vessels. Seventy-seven male patients and 77 cardiovascular disease-free controls, matched for sex, age and body weight were studied. Higher triglyceride and apo B levels with lower HDL-cholesterol and apo A-I levels were found in BP patients in comparison with the controls. Lp(a) levels were slightly, but not significantly, increased. Moreover BP patients presented a significantly higher prevalence of HDL-cholesterol levels below 35 mg dl-1 (49.3% vs 22…

Malemedicine.medical_specialtyApolipoprotein BCoronary Artery DiseaseCoronary artery diseaseInternal medicineMedicineHumansDerivationCoronary Artery BypassCoronary atherosclerosisTriglyceridesAgedApolipoproteins BAnalysis of VarianceChi-Square DistributionbiologyApolipoprotein A-Ibusiness.industryCholesterol HDLLipoprotein(a)Middle Agedmedicine.diseaseStenosisBypass surgeryCoronary vesselbiology.proteinCardiologyCardiology and Cardiovascular MedicinebusinessLipoprotein(a)European heart journal
researchProduct

Effects of high-intensity circuit training, low-intensity circuit training and endurance training on blood pressure and lipoproteins in middle-aged o…

2013

Background The aim of this study was to determine the physiological effects of an high-intensity circuit training (HICT) on several cardiovascular disease risk factors in healthy, overweight middle-aged subjects, and to compare the effects of HICT to traditional endurance training (ET) and low-intensity circuit training (LICT). Methods Fifty-eight participants (ages 61±3.3 yrs, BMI 29.8±0.9) were randomly assigned to one of the three exercise treatment groups: HICT, LICT and ET. The three groups exercised three times per week, 50 min per session for 12 weeks. Baseline and after intervention anthropometric characteristics: body weight (BW), fat mass (FM); blood pressure: diastolic (DBP) and …

Malemedicine.medical_specialtyApolipoprotein BHdlEndocrinology Diabetes and MetabolismsportsLipoproteinsClinical BiochemistryPhysical ExertionBlood PressureClinical nutritionOverweightCardiovascular disease risk factorsCircuit trainingLdlEndocrinologyEndurance trainingInternal medicinemedicineHumansExercise physiologyExerciseApolipoproteins ATriglyceridesAgedApolipoproteins BBiochemistry medicalCircuit trainingbiologybusiness.industryResistance training strength and conditioningResearchBiochemistry (medical)Cholesterol HDLCholesterol LDLAnthropometryMiddle AgedOverweightExercise TherapyBlood pressureEndocrinologyAdipose Tissuebiology.proteinsports.sportlipids (amino acids peptides and proteins)medicine.symptombusinessLipids in health and disease
researchProduct

Ajuga ivaaqueous extract improves reverse cholesterol transport in streptozotocin-induced diabetic rat

2012

AbstractObjectivesThe aim of this study was to determine the effects of Ajuga iva aqueous extract on lecithin : cholesterol acyltransferase (LCAT) activity and amount and composition of high-density lipoprotein (HDL)2 and (HDL)3, in streptozotocin (STZ)-induced diabetic rats.MethodsDiabetes was induced in male Wistar rats by intraperitoneal injection of STZ (60 mg/kg body weight). Diabetic rats (n = 12) were divided into two groups. The diabetic control group (D) received a 20% casein diet and the diabetic treated group received the same diet supplemented with A. iva aqueous extract (0.5 g/100 g diet) (DAi), for 4 weeks.Key findingsTotal cholesterol and HDL3-C were respectively decreased by…

Malemedicine.medical_specialtyApolipoprotein Bmedicine.medical_treatmentIntraperitoneal injectionPharmaceutical ScienceAjugaAjugaDiabetes Mellitus ExperimentalPhosphatidylcholine-Sterol O-AcyltransferaseInternal medicineDiabetes mellitusLecithinsmedicineAnimalsRats WistarPhospholipidsTriglyceridesPharmacologyApolipoprotein A-IbiologyPlant ExtractsChemistryCholesterol HDLReverse cholesterol transportBiological TransportStreptozotocinbiology.organism_classificationmedicine.diseaseRatsCholesterolEndocrinologyAcyltransferaseDietary Supplementsbiology.proteinlipids (amino acids peptides and proteins)Cholesterol EstersPhytotherapymedicine.drugLipoproteinJournal of Pharmacy and Pharmacology
researchProduct

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

2006

The type of dyslipidemia in patients with peripheral arterial disease (PAD) is still ill defined. PAD patients often show elevated triglycerides and reduced HDL-cholesterol, two lipid abnormalities usually accompanied by decreased LDL size in the "atherogenic lipoprotein phenotype" (ALP). We investigated (1) whether PAD patients have lower LDL size, (2) altered LDL subclass distribution and (3) the prevalence of ALP. We measured plasma lipids and LDL size and subclasses by gradient gel electrophoresis in 31 adults with intermittent claudication and 31 age-BMI-matched controls. Patients had higher prevalence of hypertension (p = .0132), smoking (p < .0020) and diabetes (p = .0024), with lowe…

Malemedicine.medical_specialtyAtherogenic lipoprotein phenotypeLDL sizeTriglyceridechemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseaseMedicineHumansRisk factorParticle SizeTriglyceridesAgedDyslipidemiasPeripheral Vascular DiseasesTriglyceridebusiness.industryVascular diseaseCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseAtherosclerosisIntermittent claudicationHDL-cholesterolEndocrinologyPhenotypechemistrylipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoprotein
researchProduct

Mediterranean Diet Reduces the Adverse Effect of the TCF7L2-rs7903146 Polymorphism on Cardiovascular Risk Factors and Stroke Incidence

2013

OBJECTIVE Transcription factor 7-like 2 (TCF7L2) polymorphisms are strongly associated with type 2 diabetes, but controversially with plasma lipids and cardiovascular disease. Interactions of the Mediterranean diet (MedDiet) on these associations are unknown. We investigated whether the TCF7L2-rs7903146 (C&amp;gt;T) polymorphism associations with type 2 diabetes, glucose, lipids, and cardiovascular disease incidence were modulated by MedDiet. RESEARCH DESIGN AND METHODS A randomized trial (two MedDiet intervention groups and a control group) with 7,018 participants in the PREvención con DIetaMEDiterránea study was undertaken and major cardiovascular events assessed. Data were analyzed at b…

Malemedicine.medical_specialtyCardiovascular and Metabolic RiskMediterranean dietEndocrinology Diabetes and MetabolismPopulationType 2 diabetesDiet MediterraneanGastroenterologylaw.inventionRandomized controlled triallawRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineOdds RatioHumanseducationTriglyceridesOriginal ResearchAgedAdvanced and Specialized Nursingeducation.field_of_studyPolymorphism Geneticbusiness.industryIncidenceHazard ratioOdds ratioFastingMiddle Agedmedicine.diseaseStrokeEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesFemalebusinessTCF7L2Transcription Factor 7-Like 2 ProteinDiabetes Care
researchProduct

Dietary fat interacts with the -514CT polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: th…

2003

We have previously reported an interaction between -514CT polymorphism at the hepatic lipase (HL) gene and dietary fat on high-density lipoprotein-cholesterol (HDL-C) metabolism in a representative sample of white subjects participating in the Framingham Heart Study. Replication of these findings in other populations will provide proof for the relevance and consistency of this marker as a tool for risk assessment and more personalized cardiovascular disease prevention. Therefore, we examined this gene-nutrient interaction in a representative sample of Singaporeans (1324 Chinese, 471 Malays and 375 Asian Indians) whose dietary fat intake was recorded by a validated questionnaire. When no str…

Malemedicine.medical_specialtyChinaGenotypeMedicine (miscellaneous)IndiaBiologyPolymerase Chain ReactionPolymorphism Single Nucleotidechemistry.chemical_compoundFramingham Heart StudyAsian PeopleInternal medicineGenotypeBlood plasmamedicineEthnicityHumansPromoter Regions GeneticTriglyceridesDNA PrimersNutrition and Dieteticsmedicine.diagnostic_testTriglycerideBase SequenceCholesterolConfoundingMalaysiaLipaseDietary FatsEndocrinologychemistryLiverFemaleHepatic lipaseLipid profileThe Journal of nutrition
researchProduct

Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

2004

The endogenous ligands of cannabinoid receptors, also known as endocannabinoids, have been implicated in many physiological and pathological processes of the central nervous system. Here we show that the levels of the two major endocannabinoids, anandamide and 2-arachidonoyl-glycerol (2-AG), in four areas of the rat brain, change dramatically between the light and dark phases of the day. While anandamide levels in the nucleus accumbens, pre-frontal cortex, striatum and hippocampus were significantly higher in the dark phase, the opposite was observed with 2-AG, whose levels were significantly higher during the light phase in all four regions. We found that the activity of the fatty acid ami…

Malemedicine.medical_specialtyDiacylglycerol lipaseCannabinoid receptorPolyunsaturated Alkamidesmedicine.medical_treatmentPhotoperiod2-ArachidonoylglycerolArachidonic AcidsAmidohydrolasesGlyceridesRats Sprague-DawleyCellular and Molecular Neurosciencechemistry.chemical_compoundFatty acid amide hydrolaseInternal medicineCannabinoid Receptor ModulatorsmedicineanandamideAnimals2-arachidonoylglycerol; anandamide; cannabinoid; circadian; faahMolecular BiologyPharmacologybiologyBrainCell BiologyAnandamidefaahcannabinoidEndocannabinoid system2-arachidonoylglycerolCircadian RhythmRatsMonoacylglycerol lipaseEndocrinologycircadianchemistryBiochemistrybiology.proteinMolecular MedicineCannabinoidEndocannabinoidsCellular and molecular life sciences : CMLS
researchProduct

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type…

2011

Summary Background & aims Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. Although dietary fat contributes substantially to the accumulation of liver fat, the role of individual fatty acids in this accumulation is unclear. Objective In this study, we set out to determine whether liver fat content (LFC), was associated with red blood cell fatty acid (RBC-FA) composition in people with type 2 diabetes. Design, settings, and participants One hundred and sixty-two type 2 diabetic patients were included in this study. LFC was measured using 1H-MR Spectroscopy. RBC-FA composition was measured by gas chromatography. Results One…

Malemedicine.medical_specialtyErythrocytesPalmitic AcidCritical Care and Intensive Care MedicineFatty Acids Monounsaturatedchemistry.chemical_compoundNon-alcoholic Fatty Liver DiseaseFatty Acids Omega-6Internal medicineFatty Acids Omega-3PrevalencemedicineHumansPalmitoleic acidProspective StudiesTriglyceridesAgedchemistry.chemical_classificationNutrition and Dieteticsbusiness.industryFatty liverFatty acidMiddle Agedmedicine.diseaseDietary FatsFatty LiverCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2chemistryDocosahexaenoic acidDietary SupplementsSaturated fatty acidFemaleArachidonic acidSteatosisbusinessPolyunsaturated fatty acidClinical Nutrition
researchProduct

Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease …

1984

The effect of a 3 month daily administration of 800 mg pentoxifylline (Trental 400 bds) or placebo was assessed under double blind crossover design in 18 patients (12 males and 6 females) with peripheral occlusive arterial disease in respect of painfree walking distance and various hemorheological and hemostasiological variables, platelet aggregation, serum cholesterol and triglycerides. In first treatment period walking distance significantly increased with pentoxifylline by 46% from baseline 121 ± 15 m and by 4% with placebo from baseline 134 ± 18 m. Pentoxifylline administration furthermore yielded significant decrease in whole blood and plasma viscosity and significant increase in eryt…

Malemedicine.medical_specialtyErythrocytesPlatelet Aggregationmedicine.medical_treatment030204 cardiovascular system & hematologyPlaceboPentoxifyllineDouble blindPlacebos03 medical and health sciences0302 clinical medicineDouble-Blind MethodMedicineHumansIn patient030212 general & internal medicineClinical efficacyPentoxifyllineTriglyceridesAgedChemotherapyClinical Trials as Topicbusiness.industryOcclusive arterial diseaseIntermittent ClaudicationMiddle AgedBlood ViscosityCrossover studySurgeryAdenosine DiphosphateCholesterolAnesthesiaTheobromineFemaleCollagenCardiology and Cardiovascular MedicinebusinessBlood Flow Velocitymedicine.drugAngiology
researchProduct